Trials / Completed
CompletedNCT05228873
Comparison of Quality of Life After Discharge of the Mild and Moderate COVID-19 Patients With or Without Herbal Medicine
Comparison of Quality of Life 3 Months After Discharge of the Mild and Moderate COVID-19 Patients With or Without Herbal Medicine (Shen Cao Gan Jiang Tang) in the Acute Stage
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- University of Medicine and Pharmacy at Ho Chi Minh City · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to see how the acute stage COVID-19 treatments by use of herbal medicine (Shen Cao Gan Jiang Tang) affect quality of life and symptoms at 3 months after hospital discharge.
Detailed description
According to the theory of Traditional medicine, the patient will suffer damage to Qi and Fluid in the acute phase and lead to damaged Yin and Qi in the post COVID-19 period. The Shen Cao Gan Jiang Tang has the effect of enhance the Protective Qi, generating Fluid, is applied to treat the mild and moderate COVID-19 in the acute phase in some hospitals in Ho Chi Minh City, Viet Nam. The hypothesis is that with the use of the Shen Cao Gan Jiang Tang, the Qi and Yin will reduce the damage, so that the patient has a better quality of life and fewer post COVID-19 symptoms compared with the standard of care group
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Shen Cao Gan Jiang Tang (Gan Cao Gan Jiang Tang with Ginseng) | Patients take Shen Cao Gan Jiang Tang (Gan Cao Gan Jiang Tang with Ginseng), one bag of decoction (90ml) two times a day for 10 days. Ingredients per formula (tang): 12 grams of honey-fried Radix Glycyrrhizae, 6 grams of Rhizoma Zingiberis (stir-baked), 6 grams of Panax Ginseng. The decoction of concentrated extract is packed into aluminum foil vacuum bag, 90ml per bag, 1 formula (tang) is equivalent to 2 bags. Patients use the decoction directly from the bag. |
Timeline
- Start date
- 2021-12-20
- Primary completion
- 2023-01-20
- Completion
- 2023-01-20
- First posted
- 2022-02-08
- Last updated
- 2023-07-28
Locations
1 site across 1 country: Vietnam
Source: ClinicalTrials.gov record NCT05228873. Inclusion in this directory is not an endorsement.